Cooper C. Collins, Chief Strategic Officer, 10% Owner at PERNIX THERAPEUTICS HOLDINGS, INC. (PTX), sold 37,452 shares at $2.29 ($87K) on 2013-12-06, disclosed to the SEC on 2013-12-10.
Scheduled sale ($87k) by Chief Strategic Officer, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.33 | 19,952 | $46K | 53.7% |
| 2 | $2.29 | 17,500 | $40K | 46.3% |
| Total | $2.31 avg | 37,452 | $87K | 100% |
| Filing → |
| TXMD | BUY | 2021-11-22 | $580K | — | Filing → |
| TXMD | BUY | 2021-08-19 | $725K | — | Filing → |
| TXMD | BUY | 2020-06-10 | $107K | — | Filing → |